Abstract
To determine the vaccine hesitancy of pneumococcal conjugate vaccines (PCVs) in a low-resource setting in China and to identify associated factors, a face-to-face questionnaire survey was conducted in the city of Guilin, China, from December 2021 to March 2022, which comprised sociodemographic information, attitudes toward vaccines and pneumonia, and PCV13 vaccination willingness and willingness to pay (WTP). Stepwise logistic regression and Tobit regression models were fitted to identify factors associated with PCV13 vaccination willingness and WTP, respectively. In total, 1254 questionnaires were included, of which 899, 254, and 101 participants showed acceptance, hesitancy, and refusal to vaccinate their children with PCV13, respectively. Only 39.07% of participants knew about PCV13 before this survey. A total of 558 (48.40%) participants accepted the full payment of vaccination, and 477 (41.37%) other participants accepted the partial payment, with a median cost of CNY 920.00. Demographics, social and psychological context, and attitudes toward vaccines were all associated with PCV13 vaccination but varied for hesitators and refusers. There is a substantial local demand for vaccinating children with PCV13 and partial payment is widely accepted. More publicity and educational efforts and a socially supportive environment are required to alleviate vaccine hesitancy.
Funder
Education Foundation of Peking Union Medical College and Bill & Melinda Gates Foundation Donation Project
Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences
Discipline Construction Funds of Population Medicine from Peking Union Medical College
Guilin Talent Mini-highland Scientific Research Project for COVID-19 Prevention and Control
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference40 articles.
1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the global burden of disease study 2017;Roth;Lancet,2018
2. Organisation mondiale de la S. pneumococcal conjugate vaccines in infants and children under 5 years of age: Who position paper—February 2019—Vaccins antipneumococciques conjugués chez les nourrissons et les enfants de moins de 5 ans: Note de synthèse de l’oms—Février 2019. Wkly. Epidemiol. Rec., 2019. 94.
3. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia;Hanada;Front. Immunol.,2018
4. Meeting of the immunization strategic advisory group of experts, November 2007—Conclusions and recommendations. Wkly. Epidemiol. Rec., 2008. 83.
5. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts’ children;Loughlin;Pediatr. Inf. Dis. J.,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献